phenol-water method of Westphal et al. (9) . Briefly, this modification involved growing the cultures for 3 days, killing the cultures with a terminal concentration of 1% formaldehyde, discarding the middle layer between the phenol and water layers, and harvesting the endotoxin from the upper layer by ultracentrifugation instead of ethanol precipitation. After resuspension of the pellet, the material was lyophilized, collected, and weighed.
As previously described (3), each endotoxin was shown to contain less than 1% protein by the method of Folin and Ciocalteu (10) , less than 1% RNA by optical density determinations at 280 and 260 nm, and to be free of detectable capsular contamination by the thiobarbituric acid technique of Warren (11) and by gas-liquid chromatography (2, 3) . The presence of lipid A was confirmed by the method of Galanos et al. (12) . All standards for chemical assays and gas-liquid chromatography were of the highest purity available from either Sigma Chemical Co., St. Louis, Me., or Calbiochem, San Diego, Calif.
Immunization. Bacteria were grown in TSB under CO2 for 48 h, harvested by centrifugation, washed three times in 0.15 M NaC1, and boiled for 2.5 h. ARer boiling, the cells were resuspended in 0.15 M NaCI and ac~usted spectrophotometrically to a concentration of 5 × 109 cells/ml. 3-kg rabbits were exsanguinated 7 days after the last of six 1.0-ml intravenous (i.v.) injections of boiled cells given three times weekly for 2 wk. Nonimmune sera was obtained from nonimmune littermates.
Antibody Determinations. Hemagglutinating antibodies were measured in microtiter plates with human group 0 erythrocytes sensitized with the appropriate alkaline-treated endotexin (13) .
Separation and Purification of
Immunoglobulins. 30-to 40-ml samples of pooled normal or immune rabbit serum were separated into 3 fractions on 5.0 × 100-cm glass columns packed with sterile Sephadex G-200 to a height of 90 cm. The eluant was phosphate-buffered saline (PBS) at pH 7.0, pumped upward from a reservoir by a peristaltic pump at 50-65 ml/h. 10-ml fractions were collected in an automatic fraction collector equipped with a 15-watt germicidal lamp. The optical density was recorded at 280 nm, and appropriate fractions were combined under sterile conditions. Chromatography of immunoglobulin classes was monitored 'by immunodiffusion against heavychain specific goat anti-rabbit IgM, IgA, and IgG. The frontal peak, which contained pure IgM by immunodiffusion, was restored to the original volume by concentration in dialysis tubing against polyethylene glycol at 4°C, and it was stored at 4°C for animal experiments. The second peak contained primarily IgG, but was contaminated with small amounts of IgA and IgM. After concentration, part of this material was stored at 4°C for animal experiments and part was further purified.
The 7S fraction was purified by chromatography over DEAE-Sephadex A-25 by the method of Hall et al. (14) . 50-to 100-ml samples were dialyzed against buffer 1 and chromatographed on a 5 x 25-cm Pharmacia column (Pharmacia Inc., Piscataway, N.J.) packed with 75 g of sterile DEAESephadex, also equilibrated in buffer 1. The protein peak eluted with buffer 1 (0.0175 M PBS at pH 6.3) was collected on the automatic fraction collector, pooled, and concentrated to a protein concentration equal to the original 7S peak (concentrated about 2 × ). This material was pure IgG by immunodiffusion and was retained for animal experiments. The second peak was eluted with 0.4 M PBS, pH 5.3. Before recharging the Sephadex by washing in buffer 1, it was treated with 1 M NaC1 and 0.1 M NaOH.
Special precautions were taken to assure sterility as previously described (4) . All sera and immunoglobulin fractions for prevention of the Shwartzman reactions were shown to be sterile and free of pyrogens. Statistical Methods. The chi-square test was used to determine whether or not there was a significant difference in the incidence of Shwartzman reactions between the groups.
Protection Against Meningoeoccal Dermal Necrosis (Local Shwartzman Phenomenon

Results
Production of Antiserum. Rabbits immunized with boiled cells ofE. coli J5 uniformly caused hemagglutination of J5-sensitized erythrocytes to a titer > 1:256 by lnicrotiter and > 1:1,000 by the tube technique. Immunization with E. coli J5 also caused a rise in hemagglutinins to meningococcal LPS generally equal to that obtained by immunization with the homologous MGC. Immunization with heterologous meningococcal boiled cells resulted in production of hemagglutinins, but the response was less uniform. The reciprocals of the hemagglutination titers are shown in Tables I, II , and III. Although protective antisera always contained hemagglutinins, there was no definite correlation between the height of the hemagglutinating antibody response and the degree of protection.
Prevention of Meningococcal Dermal Necrosis
MGC A ZN~YrOXlN. Antiserum to E. coli J5, MGC A, MGC B, and MGC C all lowered the incidence of dermal necrosis significantly below that of animals which received nonimmune serum (87% positive; Table I ). Although antisera to J5 and MGC A1 protected a larger percentage of animals (33 and 32% positive), they were not statistically more effective than antisera raised against MGC B11 and Cll (45 and 55% positive).
MGC B ENDOTOXIN. Only 28% of the rabbits given antiserum to J5 developed dermal necrosis, compared with 88% who received nonimmune serum (P<0.0005), and 59% who received heterologous meningococcal antiserum prepared against MGC A1 (Table II; P=0.01). Antiserum to MGC BI~ (serogrouphomologous) was also protective, but not superior to MGC AI antiserum. MGC C~I antiserum also protected all but 28% of the animals, but it was not superior to MGC A~ or Bll antiserum.
MGC C ENDOTOXIN. J5 antiserum protected the largest percentage of rabbits in this experiment and was superior to nonimmune and anti-meningococcal A~ sera (Table III) . Antisera against MGC B~ and CH were also protective.
COMPOSITE RESULTS. The results of the experiments shown in Tables I, II,  and III are combined in Table IV . In this table the results of protection experiments with each antiserum against all three meningococcal endotoxins are combined, so that the protective capacity of each meningococcal antiserum * Experiments were conducted as stated in the text and in Table I except that B11 endotoxin was used to prepare (1.75 ~g) and provoke (1.5 ~g) the dermal Shwartzman reactions. $ Reciprocal of hemagglutination titer against human group O erythrocytes sensitized with alkaline-treated MGC BH endotoxin. § Protection by E. coli J5 antiserum (28% positive) was superior to that from MGC A~ antiserum (59% positive), P<0.01.
is examined against heterologous as well as homologous LPS. These data show that antiserum to E. coli J5 was more protective (33% positive) than nonimmune serum (87% positive; P<0.0005), MGC A antiserum (51% positive; P<0.015), MGC B antiserum (49% positive, P<0.03), and MGC C antiserum (47% positive; P<0.06). Table V compares the results of all protection experiments with E. coli J5 antiserum to each meningococcal antiserum tested only against the serogroupheterologous endotoxins. In this analysis which represents a more realistic comparison of the cross-reactivity of antiserum and LPS, J5 antisera protected Tables VI,  VII , and VIII show that the protection afforded by J5 antiserum against renal cortical necrosis from MGC A1 (18% positive), MGC Bll (30% positive), and MGC CI~ (22% positive) was significant and at least as effective as that provided by homologous antisera. Heterologous meningococcal antisera did not prevent renal cortical necrosis induced by LPS from MGC Bll and C11 (Tables VII and  VIII) .
Protection with J5 Immunoglobulin Fractions
PumTY. The 19S fractions of whole rabbit serum chromatographed over Sephadex G-200 contained only IgM by immunodiffusion and were used in protection experiments without further purification. Because the 7Sffactions of Table VI except that BH endotoxin was used to prepare (12.5 ~g) and provoke (10 ~g) renal cortical necrosis.
both nonimmune and immune sera showed contaminating IgA, portions of each were further purified over DEAE-Sephadex A-25. The first peak eluted from the DEAE-Sephadex contained only IgG by immunodiffusion and was stored at 4°C for protection studies. 
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The 19S and 7S fractions from Sephadex G-200 were restored to the original volume of the serum before they were used in animal experiments. Normal and J5 immune IgG purified over DEAE were concentrated twofold to approximately the total protein content of the original 7S Sephadex fractions, before they were used in animal experiments.
PREVENTION OF DERMAL NECROSIS WITH IMMUNOGLOBULIN FRACTIONS.
The results of protection experiments with nonimmune and J5 immune 7S and 19S fractions from Sephadex G-200 are shown in Table IX . Immune 7S was protective (P<0.05) whether compared to nonimmune 7S, nonimmune 19S, or immune 19S. Immune 19S was not protective.
The next experiment shown in Table X compared purified nonimmune and J5 immune IgG from DEAE Sephadex with E. coli J5 antiserum. Immune IgG (10% positive) was as protective (P<0.005) as whole E. coli J5 antiserum (20% positive; P<0.003) when compared to nonimmune IgG (90% animals positive).
Discussion
We have shown in these studies that antibodies to E. coli J5, a rough mutant of E. coli 0111, can protect against the two most dramatic manifestations of meningecoccal endotoxemia: dermal purpura and renal cortical necrosis. Because this mutant is deficient in UDP-galactose epimerase, it cannot build the complex "0" antigenic side chains that mask the LPS core of most endotoxins, including E. coli 0111 and MGC A1, B11, and C,, This enzymatic block, which is equivalent to that of the Rc forms of Salmonella (15), exposes the core so that it can stimulate antibodies capable of cross-reactions with all antigenically similar endotoxin cores. It is this structural property ofE. coli J5 that is responsible for stimulating antibodies that protect against endotoxemia and bacteremia due to E. coli (4-7), Salmonella (4-6), Klebsiella (7), P. aeruginosa (8) , and meningococcal LPS, regardless of serogroup. We have shown previously that the "0" antigenic side chains, responsible for serogrouping enteric bacilli, interfere with antibody production to the antigenically similar LPS core. In these studies, antibodies to the parental form of J5, E. coli 0111, unlike J5 antibodies, would not protect against diverse gram-negative bacilli such as Klebsiella (7) and P. aeruginosa (8) .
The current study with meningococcal LPS shows that the oligosaccharide side chains of meningococcal LPS also interfere with serogroup heterologous protection. Whereas antibodies to E. coli J5 protected against dermal and renal necrosis induced by LPS from MGC A~, Bm and Cn, antibodies to MGC A~ failed to protect against dermal necrosis or renal cortical necrosis induced by MGC Cn LPS (Tables III and VIII) . Similarly, MGC C~1 failed to protect against renal cortical necrosis induced by MGC B~ (Table VII) . Although antiserum to MGC A~ prevented dermal necrosis from Bn LPS, this protection was inferior to that from J5 antibodies (Table II) . Finally, the protection by J5 antibodies against dermal necrosis induced by LPS from all three meningococcal serogroups was better than anti-meningococcal sera, even when the homologous endotoxin was included in the calculations (Table IV) . The complete absence of cross protection in some experiments shows that meningococcal endotoxins are antigenically different. Because antibodies to the common core of LPS (E. coli J5) are completely cross-reactive, this antigenic variability must reside elsewhere in the LPS complex, most likely in the "0" antigenic units. Antigenic variability of "0" side chains is well known among enteric bacilli, but has not been generally appreciated in meningococcal LPS, although Zollinger et al. (16) showed incomplete serological cross-reactivity of antisera raised against MGC B and C.
The experiments with immunoglobulin fractions ( The failure of isolated IgM to prevent dermal necrosis is puzzling. It is possible that IgM reacts with whole bacteria rather than purified LPS, or that IgM antibodies can react only with certain endotoxins. In previous studies of immunoglobulin fractions directed against the homologous endotoxin, both anti-E, coli 0111 7S and 19S fractions were protective against renal cortical necrosis induced by 0111 endotoxin (6) . Some antibodies of the IgM class should be present at 21 days when immunized rabbits were exsanguinated, but it is possible that the concentration of protective antibodies is too low to detect in animal assays.
The demonstration that purified antibodies raised against an E. coli mutant can prevent the manifestations of meningococcal endotoxemia suggests that the core of meningococcal endotoxin is the toxic moiety, and underscores the antigenic similarity of LPS from otherwise unrelated bacteria. Moreover, this antibody may provide an additional immunological weapon against meningococcemia. The pioneering work of Goldschneider et al. (18) and Gotschlich et al. (19, 20) at Walter Reed has provided capsular vaccines that prevent meningococcal disease caused by MGC of groups A and C (21-23). Unfortunately, this protection is serogroup-specific. Group B capsule is not immunogenic in man (24) , and there is no vaccine available for serogroup Y or other groups that may evolve into important pathogens. Because of the serogroup specificity of the capsular vaccines, the nonimmunogenicity of group B capsule, and the pathogenic potential of other meningococcal serogroups, investigators have turned to studies of outer membrane antigens that might cross-react between capsular groups (16, (25) (26) (27) . These studies have resulted in the identification of a number of different outer membrane serotypes that cross serogroup lines. The protective capacity of serotype antibodies against group B strains tested in chick embryos, however, appears to be serogroup-specific (28) ; in other words, antisera raised against whole MGC B of different serotypes showed primarily group-specific protection. Serogroup and serotype antibodies did appear to provide synergistic protection against the homologous serogroup.
On the other hand, antiserum raised against E. coli J5 protects rabbits from meningococcal endotoxemia regardless of serogroup. Similarly, gamma globulin prepared from these broad-spectrum antibodies should counteract the devastating effects of meningococcal endotoxemia in patients infected with any capsular serogroup.
Summary
Antibodies to Escherichia coli J5, a uridine 5'-diphosphate-galactose epimeraseless mutant of E. coli 0111, neutralized meningococcal endotoxemia from all three major capsular serogroups. We chose the dermal necrosis of the local Shwartzman phenomenon and the renal cortical necrosis of the general Shwartzman phenomenon as assays because these are the hallmarks of meningococcemia, and because meningocoecal lipopolysaccharide (LPS) is a uniquely potent cause of dermal purpura and necrosis. Meningococcal antisera raised against LPS from MGC A, B, and C also provided good protection against endotoxemia from the homologous capsular groups, but it was inconsistent against the heterologous serogroups. The superiority of J5 antibodies (purified IgG as well as antiserum) is probably due to the fact that J5 LPS contains only the endotoxin core. Consequently, immunization with this mutant stimulates production of antibodies to core LPS without interference by the 't0" antigenic determinants of the side chains.
These observations indicate that the endotoxin core is the toxic moiety of meningococcal LPS, that the core LPS of meningococcus (MGC) is immunologically similar to enteric LPS, and that the antigenically variable "0" side chains of MGC LPS interfere with antibody production against the common core. They also suggest that antibodies prepared against this E. coli mutant could interrupt the devastating course of meningococcal endotoxemia in man, regardless of the capsular serogroup of the infecting strain.
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